News from fight against cancer innovation trust A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 10, 2019, 09:00 ET FACIT Makes Follow-on Investment in AI-based genomics company, DNAstack

Capital leverages Ontario's strengths in genomics and informatics, deepens FACIT's tech portfolio TORONTO, Jan. 10, 2019 /PRNewswire/ - FACIT, a...


Oct 11, 2018, 09:00 ET Seasoned Entrepreneurs Har Grover and Ken Lawless Join FACIT Board

Strategic appointments add expertise and strengthen governance TORONTO, Oct. 11, 2018 /PRNewswire/ - FACIT announced the appointment of two new...


Sep 13, 2018, 09:00 ET FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants

Prospects Oncology Fund seeds developing pipeline of Ontario-based biotech innovations TORONTO, Sept. 13, 2018 /PRNewswire/ - With an expanding...


Jun 27, 2018, 08:30 ET Healthcare Software Start-Up Ziliomics Financed by FACIT

World-leading genomics cloud computing group builds clinical tool for cancer care in Ontario TORONTO, June 27, 2018 /PRNewswire/ - Ziliomics Inc., a...


Jun 13, 2018, 09:34 ET FACIT Appoints Biotech Veteran Dr. David O'Neill as President

Entrepreneur adds US oncology management experience to Ontario commercialization TORONTO, June 13, 2018 /PRNewswire/ - The Board of Trustees...


Apr 12, 2018, 07:00 ET Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition

Biotechnology competition modeled after popular TV program Dragons' Den TORONTO, April 12, 2018 /PRNewswire/ - A panel of investor-judges has...


Feb 20, 2018, 10:45 ET FACIT's Prospects Oncology Fund invests $450k in promising Ontario breakthrough technologies

Investment supports emerging entrepreneurial scientists and critical proof-of-principle studies TORONTO, Feb. 20, 2018 /PRNewswire/ - FACIT, a...


Nov 21, 2017, 08:48 ET FACIT Welcomes Kevin Empey, Cynthia Goh and Shana Kelley to the Board of Trustees

Trustee additions deepen entrepreneurial expertise and strengthen FACIT governance TORONTO, Nov. 21, 2017 /PRNewswire/ - FACIT announced the...


Sep 25, 2017, 09:20 ET FACIT Congratulates Portfolio Company Fusion Pharmaceuticals on its US$46 Million Oversubscribed Series A

Addition of new investors builds on Ontario's next-gen radiotherapies and cancer innovations TORONTO, Sept. 25, 2017 /PRNewswire/ - Ontario oncology...


Jul 18, 2017, 09:30 ET FACIT Launches Cross-border Campaign to Recruit Clinical Scientists and Biotechnology Industry Executives

Initiative targets expats for growing oncology company portfolio in Ontario TORONTO, July 18, 2017 /PRNewswire/ - FACIT, which commercializes...


Jul 10, 2017, 08:30 ET FACIT supports cancer research translation and invests in three talented Ontario start-ups

Prospects Fund awardees receive $375,000 for key proof-of-concept studies TORONTO, July 10, 2017 /PRNewswire/ - FACIT has announced the first three...


Jun 20, 2017, 08:30 ET FACIT Builds on Commercialization Momentum by Attracting Experienced Executive-in-Residence

Anil Amlani expands FACIT's oncology expertise in medical device sector TORONTO, June 20, 2017 /PRNewswire/ - FACIT is pleased to announce the...


Mar 22, 2017, 08:30 ET FACIT Announces Investment in Propellon Therapeutics

Seed financing of CAD$3.0M positions first-in-class WDR5 cancer therapy for clinical development TORONTO, March 22, 2017 /PRNewswire/ - FACIT...


Mar 21, 2017, 08:30 ET FACIT Launches The Prospects Oncology Fund

New evergreen fund to help Ontario discoveries reach seed-stage funding faster TORONTO, March 21, 2017 /PRNewswire/ - Fight Against Cancer Innovation ...


Feb 23, 2017, 08:41 ET FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Financing leverages and strengthens Ontario's next-generation radiotherapeutics expertise, products TORONTO, Feb. 23, 2017 /PRNewswire/ - The Fight...


Nov 02, 2016, 11:30 ET FACIT Start-up Turnstone Biologics Closes USD $41M Financing

OrbiMed, Versant-led round continues commercialization success for Turnstone's cancer therapies TORONTO, Nov. 2, 2016 /PRNewswire/ - Turnstone...


Jun 23, 2016, 01:00 ET Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers

FACIT forms biotechnology company for OICR-discovered first-in-class epigenetic modifiers TORONTO, June 23, 2016 /PRNewswire/ - FACIT has announced...


May 26, 2016, 09:30 ET Privacy Analytics Acquired by IMS Health

Integrating innovative data privacy expertise with a global healthcare information & technology service leader, strengthening and driving Ontario's...


Jan 28, 2016, 08:00 ET Trillium Therapeutics Acquires Fluorinov Pharma

Combined entity creates strong foundation for leading Canadian immuno-oncology company TORONTO, Jan. 28, 2016 /PRNewswire/ - FACIT has announced that ...


Dec 16, 2015, 09:00 ET FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

Image-guided medicines for hard to treat cancers built using next generation medical isotopes TORONTO, Dec. 16, 2015 /PRNewswire/ - FACIT and Fusion...


Dec 08, 2015, 09:00 ET FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

First-in-class epigenetic modifiers discovered by OICR positioned for collaborative development TORONTO, Dec. 8, 2015 /PRNewswire/ - Fight Against...


Oct 28, 2015, 08:00 ET FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management

Versant Ventures-led investment accelerates development, broadens oncolytic viral immunotherapy potential TORONTO, Oct. 28, 2015 /PRNewswire/ -...


Oct 14, 2015, 08:55 ET OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Research Collaboration and Option and License Agreement Reach Approximately $450 Million Cdn TORONTO, Oct. 14, 2015 /PRNewswire/ - The Ontario...


Jul 10, 2015, 11:11 ET Turnstone Biologics Announces Enrollment in Landmark Oncolytic Vaccine Trial

Marabex™ trial to assess the safety of a novel tumour-targeted oncolytic virus vaccine in patients with advanced solid tumours TORONTO, July 10, 2015 ...


May 26, 2015, 08:30 ET Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors

TORONTO, May 26, 2015 /PRNewswire/ - Fluorinov Pharma (Fluorinov), a FACIT portfolio company, today announced the appointment of Luke M. Beshar to...